Cargando…
319O The systemic pro-inflammatory response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection
Autores principales: | Dettorre, G., Diamantis, N., Loizidou, A., Piccart, M., Chester, J., Jackson, A., Tovazzi, V., Fotia, V., Sita-Lumsden, A., Bower, M., Gaidano, G., Felip, E., Ottaviani, D., Sng, C., Rimassa, L., Santoro, A., Aguilar-Company, J., Seguí, E., Dolly, S., Pinato, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680629/ http://dx.doi.org/10.1016/j.annonc.2020.10.313 |
Ejemplares similares
-
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
por: Dettorre, Gino M, et al.
Publicado: (2021) -
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
por: Pinato, David J., et al.
Publicado: (2021) -
504P SARS-CoV-2 Omicron (B.1.1.529) variant infection leads to high morbidity and mortality in unvaccinated patients with cancer
por: Pinato, D.J., et al.
Publicado: (2022) -
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective
por: Soosaipillai, Gehan, et al.
Publicado: (2021) -
1588P SARS-CoV-2 antibody seroprevalence and safety of vaccines in cancer patients who recovered from COVID-19
por: Patel, M., et al.
Publicado: (2021)